Compagnie Lombard Odier S Cm A Alnylam Pharmaceuticals, Inc. Transaction History

Compagnie Lombard Odier S Cm A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 15, 2021	SELL	$128.63 - $176.89 $0 - $0	0 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$126.83 - $175.69 $0 - $0	0 New	0 $0
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $0 - $0	0 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $32,930 - $46,395	-500 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$72.76 - $93.45 $36,380 - $46,725	500 New	500 $47,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.